Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray for prevention of acute stress disorder after emergency cesarean section
ChiCTR2600122150Phase 4Not yet recruiting
- Sponsor
- Luzhou Maternal and Child Health Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in acute stress disorder (ASD) (2 arms), sponsored by Luzhou Maternal and Child Health Hospital. Primary endpoint: Incidence of postoperative acute stress disorder. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
acute stress disorder (ASD)
Beyond the preview
Go deeper on ChiCTR2600122150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122150.